MARAVAI LIFESCIENCES HOLDINGS, INC.

Pharmaceutical Preparations

MRVI Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0001823239 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$2.42B
147,996,000 shares ≈ see note Covers every share class this company has on file.
Insiders on file
21
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$75.90M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
3.14%
insider-held value divided by market capitalisation

What MARAVAI LIFESCIENCES HOLDINGS, INC. reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$185.74M
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$130.80M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
415
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at MARAVAI LIFESCIENCES HOLDINGS, INC.

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against MARAVAI LIFESCIENCES HOLDINGS, INC..
Insider Reported role Shares Value Last action
Officers 7
William E. Martin III CEO 1,814,643 $13.28M A Grant or award Mar 17, 2025 position reported
Peter Michael Leddy Executive 727,177 $5.32M F Shares withheld for taxes Jul 15, 2025 position reported
Kevin Herde CFO 674,636 $4.94M A Grant or award May 15, 2025 position reported
Rebecca Buzzeo Executive 606,791 $4.44M F Shares withheld for taxes Mar 17, 2025 position reported
Christine Dolan Christine Dolan Executive 420,312 $3.08M A Grant or award May 15, 2026 position reported
Kurt Oreshack Kurt Oreshack General Counsel 384,991 $2.82M S Open-market sale Jun 10, 2026 position reported
Andrew Burch Executive 369,183 $2.70M F Shares withheld for taxes Jan 15, 2025 position reported
Officers who also sit on the board 4
Bernd Brust Bernd Brust CEO 2,466,771 $18.06M F Shares withheld for taxes Sep 8, 2026 position reported
Rajesh Asarpota CFO 500,000 $3.66M F Shares withheld for taxes Aug 31, 2026 position reported
Carl Hull Executive 477,072 $3.49M P Open-market purchase Nov 11, 2024 position reported
Anat Ashkenazi CFO 60,768 $444.8K A Grant or award May 23, 2024 position reported
Directors 10
R. Andrew Eckert Board Member 365,890 $2.68M A Grant or award May 26, 2026 position reported
Gregory T. Lucier Board Member 264,907 $1.94M G Bona fide gift Jun 9, 2026 position reported
Jessica Hopfield Board Member 199,907 $1.46M A Grant or award Jun 16, 2025 position reported
Susannah Gray Susannah Gray Board Member 169,907 $1.24M A Grant or award May 26, 2026 position reported
John A DeFord John A DeFord Board Member 159,185 $1.17M A Grant or award May 26, 2026 position reported
Murali Prahalad Board Member 154,607 $1.13M A Grant or award Jun 16, 2025 position reported
Benjamin James Daverman Board Member 138,055 $1.01M A Grant or award Jun 16, 2025 position reported
Constantine S. Mihas Board Member 138,055 $1.01M A Grant or award May 26, 2026 position reported
Luke Joseph Marker Luke Joseph Marker Board Member 138,055 $1.01M A Grant or award May 26, 2026 position reported
Sean Laurence Cunningham Sean Laurence Cunningham Board Member 138,055 $1.01M A Grant or award May 26, 2026 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Gregory T. Lucier bought 51,472 MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) shares for $190,446 on Dec 5, 2025

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Gregory T. Lucier bought 51,472 MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) shares for $190,446 on Dec 5, 2025
Date Insider Transaction Shares Price Value Filing
Dec 5, 2025 Gregory T. Lucier P Open-market purchase 51,472 held after: 106,595 $3.70 $190,446 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 97 rows we hold, 7 are open-market purchases (P) and 3 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for MARAVAI LIFESCIENCES HOLDINGS, INC., newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Sep 8, 2026 Bernd Brust F Shares withheld for taxes 29,250 $7.32 $214.1K SEC filing ↗
Aug 31, 2026 Rajesh Asarpota F Shares withheld for taxes 5,465 $7.68 $42.0K SEC filing ↗
Aug 10, 2026 Bernd Brust F Shares withheld for taxes 29,250 $6.23 $182.2K SEC filing ↗
Jul 30, 2026 Rajesh Asarpota F Shares withheld for taxes 5,465 $6.59 $36.0K SEC filing ↗
Jul 8, 2026 Bernd Brust F Shares withheld for taxes 29,250 $5.92 $173.2K SEC filing ↗
Jun 30, 2026 Rajesh Asarpota F Shares withheld for taxes 65,584 $6.39 $419.1K SEC filing ↗
Jun 10, 2026 Kurt Oreshack S Open-market sale 25,000 $5.10 $127.5K SEC filing ↗
Jun 9, 2026 Kurt Oreshack S Open-market sale 25,000 $5.06 $126.5K SEC filing ↗
Jun 9, 2026 Gregory T. Lucier G Bona fide gift 46,293 $0.00 $0 SEC filing ↗
Jun 9, 2026 Gregory T. Lucier G Bona fide gift 46,293 $0.00 $0 SEC filing ↗
Jun 8, 2026 Bernd Brust F Shares withheld for taxes 351,001 $5.02 $1.76M SEC filing ↗
May 26, 2026 Susannah Gray A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 26, 2026 Luke Joseph Marker A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 26, 2026 Sean Laurence Cunningham A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 26, 2026 John A DeFord A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 26, 2026 Constantine S. Mihas A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 26, 2026 Gregory T. Lucier A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 26, 2026 R. Andrew Eckert A Grant or award 46,293 $0.00 $0 SEC filing ↗
May 15, 2026 Kurt Oreshack A Grant or award 776 $2.84 $2.2K SEC filing ↗
May 15, 2026 Christine Dolan A Grant or award 5,006 $1.79 $9.0K SEC filing ↗
Mar 16, 2026 Kurt Oreshack F Shares withheld for taxes 39,976 $3.08 $123.1K SEC filing ↗
Mar 16, 2026 Christine Dolan F Shares withheld for taxes 28,661 $3.08 $88.3K SEC filing ↗
Jan 15, 2026 Kurt Oreshack F Shares withheld for taxes 31,902 $3.69 $117.7K SEC filing ↗
Jan 15, 2026 Christine Dolan F Shares withheld for taxes 28,934 $3.69 $106.8K SEC filing ↗
Dec 8, 2025 Gregory T. Lucier P Open-market purchase 48,528 $3.67 $178.1K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Corporate ownership links — 8 filers hold a position

Who owns MARAVAI LIFESCIENCES HOLDINGS, INC.

Each row is one filer naming this company.

Funds, trusts and other companies file the same ownership forms that executives do. Everything below is taken from those filings, with the position exactly as the filing states it.

Do not add these figures together. 8 of the positions below were reported on filings shared by several filers at once.

Why the same shares appear twice

On a joint filing every named filer is listed against the whole position, so the same block of stock appears under each name. Those rows are marked joint.

Filers holding a position in MARAVAI LIFESCIENCES HOLDINGS, INC.

Funds, trusts and companies that disclose an ownership position in MARAVAI LIFESCIENCES HOLDINGS, INC..
Owner Reported role Shares Filed
GTCR CO-INVEST XI LP Director,TenPercentOwner 130,834,085 joint
GTCR FUND XI/B LP Director,TenPercentOwner 130,834,085 joint
GTCR FUND XI/C LP Director,TenPercentOwner 130,834,085 joint
GTCR INVESTMENT XI LLC Director,TenPercentOwner 130,834,085 joint
GTCR PARTNERS XI/A&C LP Director,TenPercentOwner 130,834,085 joint
GTCR PARTNERS XI/B LP Director,TenPercentOwner 130,834,085 joint
MARAVAI LIFE SCIENCES HOLDINGS 2, LLC Director,TenPercentOwner 130,834,085 joint
MARAVAI LIFE SCIENCES HOLDINGS, LLC Director,TenPercentOwner 130,834,085 joint

See the full ownership map — every entity that files as an owner of a US public company.

Subsidiaries — 10 legal entities

Subsidiaries of MARAVAI LIFESCIENCES HOLDINGS, INC.

10 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries MARAVAI LIFESCIENCES HOLDINGS, INC. names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
Alphazyme, LLC Delaware
Cygnus Technologies, LLC Delaware
Glen Research, LLC Delaware
Maravai Intermediate Holdings, LLC Delaware
Maravai LifeSciences Deutschland GmbH Germany
Maravai LifeSciences International Holdings, Inc. Delaware
Maravai Topco Holdings, LLC Delaware
MLSA Holdings, LLC Delaware
MyChem, LLC California
TriLink Biotechnologies, LLC Delaware
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: weighted average over the reporting period (us-gaap:WeightedAverageNumberOfSharesOutstandingBasic), taken from MARAVAI LIFESCIENCES HOLDINGS, INC.’s own filings and multiplied by our closing price. ≈ Not a single-day figure — treat this market cap and its rank as approximate. Full method.

What that share count means

this company did not tag a cover-page share count we could read, so the figure is the average number of shares outstanding across the whole reporting period rather than a count on any single day. If the company issued or bought back stock during the period, the true count today is higher or lower than this.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from MARAVAI LIFESCIENCES HOLDINGS, INC.’s own SEC filings multiplied by the closing price we hold for the same stock.